Net Cash Provided by (Used in) Financing Activities in USD of NEOGENOMICS INC from 2010 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
NEOGENOMICS INC quarterly/annual Net Cash Provided by (Used in) Financing Activities history and change rate from 2010 to Q1 2025.
  • NEOGENOMICS INC Net Cash Provided by (Used in) Financing Activities for the quarter ending 31 Mar 2025 was $949K, a 16.3% increase year-over-year.
  • NEOGENOMICS INC annual Net Cash Provided by (Used in) Financing Activities for 2024 was $4.65M, a 2.02% increase from 2023.
  • NEOGENOMICS INC annual Net Cash Provided by (Used in) Financing Activities for 2023 was $4.55M, a 61.5% decline from 2022.
  • NEOGENOMICS INC annual Net Cash Provided by (Used in) Financing Activities for 2022 was $11.8M, a 98.4% decline from 2021.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)

NEOGENOMICS INC Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 $949K +$133K +16.3% 01 Jan 2025 31 Mar 2025 10-Q 29 Apr 2025
Q1 2024 $816K -$563K -40.8% 01 Jan 2024 31 Mar 2024 10-Q 29 Apr 2025
Q1 2023 $1.38M -$4.68M -77.2% 01 Jan 2023 31 Mar 2023 10-Q 30 Apr 2024
Q1 2022 $6.06M -$519M -98.8% 01 Jan 2022 31 Mar 2022 10-Q 09 May 2023
Q1 2021 $525M +$524M +84979% 01 Jan 2021 31 Mar 2021 10-Q 09 May 2022
Q1 2020 $617K +$134K +27.7% 01 Jan 2020 31 Mar 2020 10-Q 06 May 2021
Q1 2019 $483K +$7.73M 01 Jan 2019 31 Mar 2019 10-Q 29 Apr 2020
Q1 2018 -$7.25M -$10.5M -326% 01 Jan 2018 31 Mar 2018 10-Q 08 May 2019
Q1 2017 $3.2M 01 Jan 2017 31 Mar 2017 10-Q 08 May 2018
Q1 2013 $4.33M +$1.82M +72.7% 01 Jan 2013 31 Mar 2013 10-Q 13 May 2013
Q1 2012 $2.51M -$544K -17.8% 01 Jan 2012 31 Mar 2012 10-Q 13 May 2013
Q1 2011 $3.05M 01 Jan 2011 31 Mar 2011 10-Q 14 May 2012

NEOGENOMICS INC Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $4.65M +$92K +2.02% 01 Jan 2024 31 Dec 2024 10-K 18 Feb 2025
2023 $4.55M -$7.28M -61.5% 01 Jan 2023 31 Dec 2023 10-K 18 Feb 2025
2022 $11.8M -$713M -98.4% 01 Jan 2022 31 Dec 2022 10-K 18 Feb 2025
2021 $725M +$490M +208% 01 Jan 2021 31 Dec 2021 10-K 20 Feb 2024
2020 $236M +$76.1M +47.7% 01 Jan 2020 31 Dec 2020 10-K 24 Feb 2023
2019 $159M +$67.5M +73.4% 01 Jan 2019 31 Dec 2019 10-K 25 Feb 2022
2018 $92M +$96.1M 01 Jan 2018 31 Dec 2018 10-K 25 Feb 2021
2017 -$4.1M 01 Jan 2017 31 Dec 2017 10-K 28 Feb 2020
2013 $2.75M -$634K -18.7% 01 Jan 2013 31 Dec 2013 10-K 24 Feb 2014
2012 $3.38M +$1.03M +43.5% 01 Jan 2012 31 Dec 2012 10-K 24 Feb 2014
2011 $2.36M -$75K -3.08% 01 Jan 2011 31 Dec 2011 10-K 24 Feb 2014
2010 $2.43M 01 Jan 2010 31 Dec 2010 10-K 12 Mar 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.